---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-303940"
form_type: "8-K"
ticker: "NOVT"
cik: "0001076930"
company_name: "NOVANTA INC"
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:50:49.819314+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Novanta appoints Alexander Manganiello as General Counsel and Corporate Secretary

## Summary
- Appointed Alexander Manganiello as General Counsel and Corporate Secretary effective December 1, 2025.
- Prior role: VP, Deputy General Counsel at Vertex Pharmaceuticals (2019-2025).
- Previously held senior legal roles at Pfizer Inc. (2004-2019) and practiced at Ropes & Gray.
- Holds A.B. Biology from Harvard University and J.D. from Suffolk Law School.

## SEC filing metadata
- accession: 0001193125-25-303940
- form_type: 8-K
- ticker: NOVT
- cik: 0001076930
- company_name: NOVANTA INC
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1076930/000119312525303940/0001193125-25-303940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1076930/000119312525303940/novt-20251201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-303940
- JSON: https://secwatch.observer/filing/0001193125-25-303940.json
- Plain text: https://secwatch.observer/filing/0001193125-25-303940.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.